bamlanivimab and etesevimab
baricitinib

Skip to main content

Welcome

Information about the Emergency Use Authorization (EUA) of Eli Lilly and Company (Lilly) Products

Privacy Statement

Accessibility Statement

This site is intended for US residents aged 18 or older.

PP-LI-US-0385 06/2021 ©Lilly USA, LLC 2021. All rights reserved.

Olumiant is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

All product/company names shown herein are the trademarks of their respective owners.

Terms of Use Privacy Statement Accessibility Statement Sitemap

Are you a consumer or a US healthcare provider?

Please confirm below.